Knowns and Unknowns: the Safety and Efficacy of Cancer Immunotherapy in Chronic Liver Disease David M. ChascsaJorge Rakela Invited Commentary 21 June 2018 Pages: 153 - 155
Extrahepatic Manifestations of Chronic Hepatitis B Infection Victor VirlogeuxChristian Trépo Hepatitis B (JK Lim, Section Editor) 13 June 2018 Pages: 156 - 165
Management of Autoimmune Hepatitis Patients Refractory to or Intolerant of Standard Therapies Keaton R. JonesCraig S. Lammert Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and C Bowlus, Section Editors) 16 May 2018 Pages: 166 - 174
Is Exercise Beneficial and Safe in Patients with Cirrhosis and Portal Hypertension? Elliot B. TapperRoberto Martinez-MaciasAndres Duarte-Rojo Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors) 02 June 2018 Pages: 175 - 183
Treatment of Gastro-Fundal Varices (Including a Discussion of BRTO) Zachary Henry Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors) 10 July 2018 Pages: 184 - 192
Innovative Care Models in Liver Disease: the Role of Multidisciplinary Teams Avegail FloresChanda K. HoSumeet K. Asrani Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors) 05 July 2018 Pages: 193 - 199
The Role of Anticoagulation in Treating Portal Hypertension Laura TurcoFilippo SchepisErica Villa Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors) Open access 18 June 2018 Pages: 200 - 208
Portal Hypertension Reverses Following Successful Antiviral Treatment for HCV: Fact or Fiction? Sabela LensClaudia BerbelJuan Carlos GarcÃa-Pagán Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors) 11 June 2018 Pages: 209 - 217
The Portosystemic Shunt Syndrome and Role of Shunt Embolization in the Management of Hepatic Encephalopathy Michael D. LeiseBrett E. Fortune Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors) 23 July 2018 Pages: 218 - 224
DILI Associated with Skin Reactions Sahand Rahnama-MoghadamHans L. Tillmann Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors) 12 July 2018 Pages: 225 - 234
Drug-Induced Liver Injury: Understanding the Different Immune-Mediated Phenotypes and Clinical Management Ben L. DaGil Ben-YakovChristopher Koh Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors) 18 June 2018 Pages: 235 - 244
Drug-induced Liver Injury Associated with Weight Loss Supplements James WalterVictor NavarroSimona Rossi Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors) 21 June 2018 Pages: 245 - 253
Uncommon Presentations of Idiosyncratic Drug-Induced Liver Injury Raj VuppalanchiMarwan Ghabril Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors) 17 July 2018 Pages: 254 - 259
Drug-Induced Fatty Liver Disease Niharika SamalaNaga Chalasani Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors) 21 July 2018 Pages: 260 - 269
Beware of HCV and HEV in Patients with Suspected Drug-Induced Liver Injury Priya GrewalJawad Ahmad Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors) 11 July 2018 Pages: 270 - 275
Novel Approaches to Causality Adjudication in Drug-Induced Liver Disease Hans L. TillmannHuiman X. BarnhartDon C. Rockey Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors) 11 July 2018 Pages: 276 - 282
Drug-Induced Liver Injury in Children Frank DiPaolaJean P. Molleston Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors) 14 July 2018 Pages: 283 - 291
Long-Term Outcomes After Drug-Induced Liver Injury Paul H. HayashiEinar S. Bjornsson Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors) 02 July 2018 Pages: 292 - 299
Correction: Assessment and Management of Sleep Disturbance in Cirrhosis Chiara FormentinMaria GarridoSara Montagnese Correction Open access 23 May 2018 Pages: 300 - 300